Related Experiment Video
Updated: Jul 5, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Expression of K+ channels in normal and cancerous human breast
Marie Brevet1, Ahmed Ahidouch, Henri Sevestre
1Laboratoire de Physiologie Cellulaire et Moléculaire, EA 2086, Faculté des Sciences, Amiens, France. brevet.marie@chu-amiens.fr
Abstract:
Potassium (K+) channels contribute to the regulation of cell proliferation and apoptosis and are also involved in tumor generation and malignant growth. Using immunohistochemical analysis, we investigated the expression of four K+ channels GIRK1 (G-Protein Inwardly Rectifying Potassium Channel 1), Ca2+-activated K channel (K Ca 1.1), voltage activated K+ channels (KV 1.1 and KV 1.3) and of the anti-apoptotic protein Bcl2 in normal and cancerous breast tissues and compared their expression with clinicopathological data. GIRK1 was overexpressed in carcinomatous tissues. In contrast, K V 1.1 and K V 1.3 were less expressed in cancerous tissue. The expression of Bcl-2 was similar in both tissues. As to the clinicopathological data, a correlation between K Ca 1.1 channel and estrogen receptor (ER) expression was observed. GIRK1 was overexpressed in breast carcinoma suggesting its involvement in proliferation and oncogenesis and its possible use as a putative pharmaceutical target. The correlation between K Ca 1.1 channel and ER suggests the involvement of this channel in proliferation. The loss of expression of the two channels K V 1.1 and K V 1.3 may correspond to their role in apoptosis.
Insights
Potassium channels are implicated in breast cancer. GIRK1 channel overexpression suggests a role in tumor growth, while reduced KV 1.1 and KV 1.3 expression may relate to apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Cell Physiology
Background:
- Potassium (K+) channels regulate critical cellular processes, including proliferation and apoptosis.
- Dysregulation of K+ channels is linked to tumor development and malignant progression.
- Specific K+ channels and their roles in breast cancer require further investigation.
Purpose of the Study:
- To investigate the expression of GIRK1, K Ca 1.1, KV 1.1, and KV 1.3 channels in normal and cancerous breast tissues.
- To compare K+ channel expression with the anti-apoptotic protein Bcl-2 and clinicopathological data.
- To explore the potential role of these K+ channels in breast cancer pathogenesis and as therapeutic targets.
Main Methods:
- Immunohistochemical analysis was employed to assess the expression of four K+ channels and Bcl-2.
- Expression levels were quantified in both normal and cancerous breast tissue samples.
- Correlations between channel expression and clinicopathological parameters, including estrogen receptor (ER) status, were examined.
Main Results:
- GIRK1 (G-Protein Inwardly Rectifying Potassium Channel 1) was significantly overexpressed in breast carcinoma tissues.
- KV 1.1 and KV 1.3 (voltage-activated K+ channels) showed reduced expression in cancerous tissues compared to normal tissues.
- K Ca 1.1 (Ca2+-activated K channel) expression correlated with estrogen receptor (ER) status.
Conclusions:
- Overexpression of GIRK1 in breast cancer suggests its involvement in proliferation and oncogenesis, positioning it as a potential therapeutic target.
- The correlation between K Ca 1.1 and ER indicates a role for this channel in breast cancer proliferation.
- Decreased expression of KV 1.1 and KV 1.3 may be associated with their role in apoptosis regulation within breast cancer.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
